ESC Professional Premium Access

Emerging role of RNAs as treatment targets in cardiovascular disease

Event: ESC Congress 2022
Topic: Cardiovascular Pharmacotherapy
Session type: Symposium
Date: 26 August 2022
Time: 16:30 - 17:30

Congress Session

Become an ESC Professional member to access this resource

Become a member

Already a member? Sign in

4 presentations in this session

Targeting RNA to reverse pathological cardiac hypertrophy.

Speaker: Professor T. Thum (Hannover, DE)
Thumbnail

Targeting RNA to facilitate cardiac remodelling and to treat heart failure.

Speaker: Mrs P. da Costa Martins (Maastricht, NL)
Thumbnail

Targeting RNA for treatment of dyslipidaemias.

Speaker: Professor S. Tsimikas (San Diego, US)
Thumbnail

Emerging role of RNAs as treatment targets in cardiovascular disease – discussion.

Thumbnail

3 speakers from this session

Professor Thomas Thum

Institute for Molecular and Translational Therapeutic Strategies (IMTTS), Hannover (Germany)
16 presentations
0 follower

Mrs Paula da Costa Martins

Faculty of Health, Medicine and Life Sciences Maastricht University, Maastricht (Netherlands (The))
3 presentations
0 follower

Professor Sotirios Tsimikas

University of California San Diego, San Diego (United States of America)
6 presentations
0 follower

This platform is supported by

logo Novo Nordisk